GC Biopharma/Novel Pharma’s Sanfilippo Syndrome Treatment Obtains FDA IND Approval By Investing.com
YONGIN, South Korea, May 20, 2024 /PRNewswire/ -- GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed ...
Tag: BiopharmaNovel
The latest news and updates about the AI Technology and Latest Tech Updates around the world... PouroverAI keeps you in the loop.